Literature DB >> 29124751

Detailed characterization of human Mycobacterium tuberculosis specific HLA-E restricted CD8+ T cells.

Teresa Prezzemolo1,2, Krista E van Meijgaarden1, Kees L M C Franken1, Nadia Caccamo2, Francesco Dieli2, Tom H M Ottenhoff1, Simone A Joosten1.   

Abstract

HLA-E presented antigens are interesting targets for vaccination given HLA-Es' essentially monomorphic nature. We have shown previously that Mycobacterium tuberculosis (Mtb) peptides are presented by HLA-E to CD8+ effector T cells, but the precise phenotype and functional capacity of these cells remains poorly characterized. We have developed and utilized in this study a new protocol combining HLA-E tetramer with intracellular staining for cytokines, transcription factors and cytotoxic molecules to characterize these cells in depth. We confirm in this study the significantly increased ex vivo frequency of Mtb-peptide/HLA-E-TM+ CD8+ T cells in the circulation of patients with active tuberculosis (TB). HLA-E restricted CD8+ T cells from TB patients produced more IL-13 than cells from controls or subjects with latent tuberculosis infection (LTBI). Compared to total CD8+ T cells, HLA-E restricted cells produced more IFNγ, IL-4, IL-10, and granulysin but less granzyme-A. Moreover, compared to "classical" Mtb specific HLA-A2 restricted CD8+ T cells, HLA-E restricted CD8+ T cells produced less TNFα and perforin, but more IL-4. In conclusion, HLA-E restricted- Mtb specific cells can produce Th2 cytokines directly.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Active TB; CD8+ T cells; Cytokines; Tetramers; Th2

Mesh:

Substances:

Year:  2017        PMID: 29124751      PMCID: PMC6266868          DOI: 10.1002/eji.201747184

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  38 in total

1.  The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.

Authors:  G B Cohen; R T Gandhi; D M Davis; O Mandelboim; B K Chen; J L Strominger; D Baltimore
Journal:  Immunity       Date:  1999-06       Impact factor: 31.745

2.  Double- and monofunctional CD4⁺ and CD8⁺ T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals.

Authors:  Susanna Commandeur; May Y Lin; Krista E van Meijgaarden; Annemieke H Friggen; Kees L M C Franken; Jan W Drijfhout; Gro E Korsvold; Fredrik Oftung; Annemieke Geluk; Tom H M Ottenhoff
Journal:  Eur J Immunol       Date:  2011-08-30       Impact factor: 5.532

3.  HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.

Authors:  K L Collins; B K Chen; S A Kalams; B D Walker; D Baltimore
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

4.  Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature.

Authors:  T F Brewer
Journal:  Clin Infect Dis       Date:  2000-09       Impact factor: 9.079

5.  Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans.

Authors:  A Geluk; K E van Meijgaarden; K L Franken; J W Drijfhout; S D'Souza; A Necker; K Huygen; T H Ottenhoff
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

6.  T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection.

Authors:  Y A Skeiky; P J Ovendale; S Jen; M R Alderson; D C Dillon; S Smith; C B Wilson; I M Orme; S G Reed; A Campos-Neto
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

Review 7.  The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.

Authors:  Rein M G J Houben; Peter J Dodd
Journal:  PLoS Med       Date:  2016-10-25       Impact factor: 11.069

8.  Salmonella Typhi-specific multifunctional CD8+ T cells play a dominant role in protection from typhoid fever in humans.

Authors:  Stephanie Fresnay; Monica A McArthur; Laurence Magder; Thomas C Darton; Claire Jones; Claire S Waddington; Christoph J Blohmke; Brian Angus; Myron M Levine; Andrew J Pollard; Marcelo B Sztein
Journal:  J Transl Med       Date:  2016-03-01       Impact factor: 5.531

9.  MHC Ib molecule Qa-1 presents Mycobacterium tuberculosis peptide antigens to CD8+ T cells and contributes to protection against infection.

Authors:  Yao Bian; Shaobin Shang; Sarah Siddiqui; Jie Zhao; Simone A Joosten; Tom H M Ottenhoff; Harvey Cantor; Chyung-Ru Wang
Journal:  PLoS Pathog       Date:  2017-05-05       Impact factor: 6.823

10.  HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells.

Authors:  Jacob Nattermann; Hans Dieter Nischalke; Valesko Hofmeister; Bernd Kupfer; Golo Ahlenstiel; Georg Feldmann; Jiirgen Rockstroh; Elisabeth H Weiss; Tilman Sauerbruch; Ulrich Spengler
Journal:  Antivir Ther       Date:  2005
View more
  17 in total

1.  Friends and foes of tuberculosis: modulation of protective immunity.

Authors:  S Brighenti; S A Joosten
Journal:  J Intern Med       Date:  2018-05-27       Impact factor: 8.989

2.  Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria.

Authors:  Samuel J Balin; Matteo Pellegrini; Eynav Klechevsky; Sohui T Won; David I Weiss; Aaron W Choi; Joshua Hakimian; Jing Lu; Maria Teresa Ochoa; Barry R Bloom; Lewis L Lanier; Steffen Stenger; Robert L Modlin
Journal:  Sci Immunol       Date:  2018-08-31

3.  Identification of HLA-E Binding Mycobacterium tuberculosis-Derived Epitopes through Improved Prediction Models.

Authors:  Paula Ruibal; Kees L M C Franken; Krista E van Meijgaarden; Marjolein van Wolfswinkel; Ian Derksen; Ferenc A Scheeren; George M C Janssen; Peter A van Veelen; Charlotte Sarfas; Andrew D White; Sally A Sharpe; Fabrizio Palmieri; Linda Petrone; Delia Goletti; Thomas Abeel; Tom H M Ottenhoff; Simone A Joosten
Journal:  J Immunol       Date:  2022-09-12       Impact factor: 5.426

Review 4.  Antigen presentation by MHC-E: a putative target for vaccination?

Authors:  Linda Voogd; Paula Ruibal; Tom H M Ottenhoff; Simone A Joosten
Journal:  Trends Immunol       Date:  2022-03-31       Impact factor: 19.709

5.  Peptide Binding to HLA-E Molecules in Humans, Nonhuman Primates, and Mice Reveals Unique Binding Peptides but Remarkably Conserved Anchor Residues.

Authors:  Paula Ruibal; Kees L M C Franken; Krista E van Meijgaarden; Joeri J F van Loon; Dirk van der Steen; Mirjam H M Heemskerk; Tom H M Ottenhoff; Simone A Joosten
Journal:  J Immunol       Date:  2020-10-05       Impact factor: 5.422

Review 6.  Research and development of new tuberculosis vaccines: a review.

Authors:  Lewis K Schrager; Rebecca C Harris; Johan Vekemans
Journal:  F1000Res       Date:  2018-11-01

Review 7.  HLA-E: exploiting pathogen-host interactions for vaccine development.

Authors:  H R Sharpe; G Bowyer; S Brackenridge; T Lambe
Journal:  Clin Exp Immunol       Date:  2019-04-09       Impact factor: 4.330

Review 8.  Harnessing donor unrestricted T-cells for new vaccines against tuberculosis.

Authors:  Simone A Joosten; Tom H M Ottenhoff; David M Lewinsohn; Daniel F Hoft; D Branch Moody; Chetan Seshadri
Journal:  Vaccine       Date:  2019-04-27       Impact factor: 3.641

9.  Targeting Unconventional T Cells for Vaccination against Tuberculosis.

Authors:  Katalin A Wilkinson; Maddalena Cerrone
Journal:  Am J Respir Cell Mol Biol       Date:  2020-04       Impact factor: 6.914

10.  Harnessing HLA-E-restricted CD8 T lymphocytes for adoptive cell therapy of patients with severe COVID-19.

Authors:  Nadia Caccamo; Lucy C Sullivan; Andrew G Brooks; Francesco Dieli
Journal:  Br J Haematol       Date:  2020-06-19       Impact factor: 8.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.